Join an RSV and Pneumonia Vaccine research study that could benefit you and your community We are looking for adult volunteers to take part in the Gemini Study, a combination RSV and Pneumonia Vaccine research study that aims to learn whether a potential new (investigational) vaccine works to prevent 2 seasonal respiratory viruses, called respiratory […]
RSV and Pneumonia Vaccine Research Study Read More »
WKRN recently shared an update on Pfizer’s RSV vaccine clinical trial after early reports indicated a positive outlook. The full story and video can be viewed on WKRN’s website here, and the story is shared below. To read more about clinical trials at Clinical Research Associates, click here. NASHVILLE, Tenn. (WKRN) – A vaccine being
RSV (Respiratory Syncytial Virus) is traditionally considered a childhood infection, and it certainly infects and hospitalizes many children and infants each year in Tennessee. But, like many other viruses we get in childhood, it can return with a vengeance when we get older. The estimated average is for 177,000 hospitalizations and 14,000 deaths each year
RSV Cases in Tennessee on the Rise, Vaccine Needed Read More »
NASHVILLE, TN (WSMV) – Clinical Research Associates in Nashville is enrolling adults into their RSV vaccine study. RSV, or respiratory syncytial virus, is something typically found in children, but it can impact older adults too. RSV causes cold-like symptoms and can lead to serious illnesses — like bronchitis or pneumonia — and sometimes death. In
WSMV: Enrollment available for RSV vaccine study Read More »
The CDC issued a warning to clinicians and caregivers on June 10 regarding an inter-seasonal increase in Respiratory Syncytial Virus (RSV) cases in parts of the southern United States including Tennessee. What this means in plain English is that doctors are worried about RSV in the summer, a time in which respiratory diseases like these
Why New Cases Highlight Importance of RSV Vaccine Clinical Study Read More »
